FLT1 anticorps (C-Term)
-
- Antigène Voir toutes FLT1 Anticorps
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
-
Épitope
- C-Term
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp FLT1 est non-conjugé
-
Application
- Western Blotting (WB), Immunofluorescence (IF)
- Séquence
- CNKKAVFSRI SKFKSTRNDS TTQSNVKH
- Specificité
- This antibody recognizes the recombinant soluble VEGFR-1/FLT-1 (native) but not the recombinant soluble VEGFR-1/FLT-1 (D1-5) both produced in Insects cells. Because of the different glycosylation of insect cells compared to mammalian cells the MW of sFlt-1 (native) is about 96 kDa instead of about 110 kDa of the naturally occurring sFlt-1. The antibody did not cross react with recombinant Human soluble KDR (D1-7).
- Réactivité croisée (Details)
- Species reactivity (tested):Human.
- Purification
- Protein A Chromatography.
- Immunogène
- Peptide of the C-terminal end of native Human soluble VEGFR-1/Flt-1
- Isotype
- IgG
- Top Product
- Discover our top product FLT1 Anticorps primaire
-
-
- Indications d'application
-
Western Blot: This VEGFR1 antibody can be used at 0.5-2.0 μg/mL with the appropriatesecondary reagents to detect native Human sVEGFR-1/Flt-1. Immunofluorescence.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Restrictions
- For Research Use only
-
- Reconstitution
- Restore in sterile water to a concentration of > 0.5 mg/mL
- Buffer
- PBS, pH 7.2 without preservatives or stabilizers.
- Agent conservateur
- Without preservative
- Conseil sur la manipulation
- This product is photosensitive and should be protected from light
- Stock
- 4 °C
- Stockage commentaire
- Prior to and following reconstitution store the antibody undiluted at 2-8 °C. DO NOT FREEZE!
-
- Antigène
- FLT1 (Fms-Related tyrosine Kinase 1 (VEGFR1) (FLT1))
- Autre désignation
- VEGFR-1 / Flt-1 (FLT1 Produits)
- Synonymes
- anticorps FLT, anticorps FLT-1, anticorps VEGFR-1, anticorps VEGFR1, anticorps FLT1, anticorps flt1b, anticorps sFlt1, anticorps AI323757, anticorps Flt-1, anticorps fms related tyrosine kinase 1, anticorps FMS-related tyrosine kinase 1, anticorps vascular endothelial growth factor receptor 1, anticorps fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor), anticorps FMS-like tyrosine kinase 1, anticorps vascular endothelial growth factor receptor-1, anticorps FLT1, anticorps Flt1, anticorps CpipJ_CPIJ012087, anticorps flt1, anticorps FLT-1
- Sujet
- Three cell membrane receptor tyrosine kinases, Flt (also designated VEGF-R1), Flk-1 (also designated VEGF-R2) and Flt-4, putatively involved in the growth of endothelial cells, are characterized by the presence of seven immunoglobulinlike sequences in their extracellular domain. These receptors exhibit high degrees of sequence relatedness to each other as well as lesser degrees of relatedness to the class III receptors, including CSF-1/Fms, PDGR, SLFR/Kit and Flt-3/Flk-2. Two members of this receptor class, Flt-1 and Flk-1, have been shown to represent high affinity receptors for vascular endothelial growth factors (VEGFs). On the basis of structural similarity to Flt and Flk-1, it has been speculated that Flt-4 might represent a third receptor for either VEGF or a VEGF-related ligand.Synonyms: FLT, FLT1, FRT, Fms-like tyrosine kinase 1, Tyrosine-protein kinase FRT, Tyrosine-protein kinase receptor FLT, VEGF Receptor 1, VEGFR1, Vascular endothelial growth factor receptor 1, Vascular permeability factor receptor
- ID gène
- 2321
- NCBI Accession
- NP_001153392
- UniProt
- P17948
- Pathways
- Signalisation RTK, Signaling Events mediated by VEGFR1 and VEGFR2, VEGFR1 Specific Signals
-